Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry

Author:

Rivera-Caravaca José Miguel12,Piot Olivier3,Roldán-Rabadán Inmaculada4,Denis Arnaud5,Anguita Manuel6,Mansourati Jacques7ORCID,Pérez-Cabeza Alejandro8,Marijon Eloi9,García-Seara Javier10,Leclercq Christophe11,García-Bolao Ignacio12ORCID,Lellouche Nicolas13,Potpara Tatjana1415,Boriani Giuseppe16ORCID,Fauchier Laurent17ORCID,Lip Gregory Y H218,Marín Francisco2ORCID

Affiliation:

1. Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain

2. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom

3. Département de Rythmologie—Cardiologie 2, Centre Cardiologique du Nord, Saint-Denis, France

4. Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain

5. Département de Rythmologie, CHU Bordeaux, LIRYC Institute, Bordeaux-Pessac, France

6. Department of Cardiology, Hospital Universitario Reina Sofía, Universidad de Córdoba, Instituto Maimónides de Investigación Biomédica (IMIBIC), Córdoba, Spain

7. Department of Cardiology, Hôpital Cavale Blanche, CHRU Brest, Brest, France

8. Department of Cardiology, Hospital Clínico Universitario Virgen de la Victoria, CIBERCV, Málaga, Spain

9. Department of Cardiology, European Georges Pompidou Hospital, Paris, France

10. Department of Cardiology, Hospital Universitario de Santiago de Compostela, CIBERCV, Santiago de Compostela, Spain

11. Department of Cardiology, University of Rennes, CHU Rennes, Rennes, France

12. Department of Cardiology, Clínica Universidad de Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain

13. Department of Cardiology, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Creteil, France

14. School of Medicine, Belgrade University, Belgrade, Serbia

15. Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia

16. Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy

17. Department of Cardiology, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, EA7505, Université de Tours, France

18. Department, Denmarkof Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark

Abstract

Abstract Aims The 4S-AF scheme [Stroke risk, Symptom severity, Severity of atrial fibrillation (AF) burden, Substrate severity] has recently been described as a novel approach to in-depth characterization of AF. We aim to determine if the 4S-AF scheme would be useful for AF characterization and provides prognostic information in real-world AF patients. Methods and results The Spanish and French cohorts of the EORP-AF Long-Term General Registry were included. The baseline 4S-AF scheme was calculated and related to the primary management strategy (rhythm or rate control). Follow-up was performed at 1-year with all-cause mortality and the composite of ischaemic stroke/transient ischaemic attack/systemic embolism, major bleeding, and all-cause death, as primary endpoints. A total of 1479 patients [36.9% females, median age 72 interquartile range (IQR 64–80) years] were included. The median 4S-AF scheme score was 5 (IQR 4–7). The 4S-AF scheme, as continuous and as categorical, was associated with the management strategy decided for the patient (both P < 0.001). The predictive performances of the 4S-AF scheme for the actual management strategy were appropriate in its continuous [c-index 0.77, 95% confidence interval (CI) 0.75–0.80] and categorical (c-index 0.75, 95% CI 0.72–0.78) forms. Cox regression analyses showed that ‘red category’ classified patients in the 4S-AF scheme had a higher risk of all-cause death (aHR 1.75, 95% CI 1.02–2.99) and composite outcomes (aHR 1.60, 95% CI 1.05–2.44). Conclusion Characterization of AF by using the 4S-AF scheme may aid in identifying AF patients that would be managed by rhythm or rate control and could also help in identifying high-risk AF patients for worse clinical outcomes in a ‘real-world’ setting.

Funder

Abbott Vascular Int

AstraZeneca

Bayer AG

Boehringer Ingelheim

Boston Scientific

The Bristol Myers Squibb and Pfizer Alliance

The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company

Gedeon Richter Plc.

Novartis Pharma AG

The Bristol Myers Squibb

German Centre for Cardiovascular Research

Funding from Daiichi-Sankyo and Boehringer-Ingelheim

Sociedad Española de Trombosis y Hemostasia

European Society of Cardiology Council on Basic Cardiovascular Science

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3